← Daily Brief
The Bell BriefFrom Dr. Jennifer Bell, DDS MAGD FICD
HIGHResearchTier 1

Single-center experience in the management of medication-related osteonecrosis of the jaw

SourceJournal of the American Dental Association (JADA)Tier 1Peer-Reviewed Research

Originally at sciencedirect.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Oral surgeons, periodontists, and implantologists managing oncology or osteoporosis patients must update local MRONJ protocols after this single-center series documents outcomes and complications of current therapies.

Key points

  • Single-center retrospective series from Tel Aviv Sourasky Medical Center covering medication-related osteonecrosis of the jaw (MRONJ) cases.
  • Authors include specialists from oral & maxillofacial surgery and oncology dentistry, providing direct clinical applicability.
  • Published online 9 October 2026 in The Journal of the American Dental Association (JADA).
  • Findings focus on management strategies, not drug-specific incidence rates or national policy changes.

Who should care

SpecialistAcademia

Read the original on Journal of the American Dental Association (JADA)

Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.

Open original

Related